Skip to content
Immunotherapy Combinations for First-Line Advanced NSCLC Treatment: Clinical Insights on Current and Emerging Options episode artwork

EPISODE · Mar 29, 2022 · 9 MIN

Immunotherapy Combinations for First-Line Advanced NSCLC Treatment: Clinical Insights on Current and Emerging Options

from PeerVoice Clinical Pharmacology Video · host PeerVoice

Immunotherapy Combinations for First-Line Advanced NSCLC Treatment: Clinical Insights on Current and Emerging Options

Episode metadata supplied by the publisher feed · Published Mar 29, 2022

Embed this episode

Visit https://www.peervoice.com/QHT860 to view the entire programme with slides. After completing “Immunotherapy Combinations for First-Line Advanced NSCLC Treatment: Clinical Insights on Current and Emerging Options”, participants will be able to: Describe the role of immunotherapy-based combinations in the first-line treatment of patients with advanced non–small-cell lung cancer (NSCLC); Discuss the latest evidence of immunotherapy-based combinations in advanced NSCLC.

Distinct summary based on available episode metadata or transcript content.

Ready to play

Immunotherapy Combinations for First-Line Advanced NSCLC Treatment: Clinical Insights on Current and Emerging Options

0:00 9:31

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of PeerVoice Clinical Pharmacology Video?

This episode is 9 minutes long.

When was this PeerVoice Clinical Pharmacology Video episode published?

This episode was published on March 29, 2022.

Can I download this PeerVoice Clinical Pharmacology Video episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!